Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Published Online
on January 12, 2004

Hypertension. 2004
Published online before print January 12, 2004, doi: 10.1161/01.HYP.0000112225.27560.24
A more recent version of this article appeared on February 1, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/2/364    most recent
01.HYP.0000112225.27560.24v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francois, H.
Right arrow Articles by Coffman, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francois, H.
Right arrow Articles by Coffman, T. M.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Animal models of human disease
Right arrow Genetically altered mice
Right arrow Hypertension - basic studies

Submitted on September 29, 2003
Revised on November 5, 2003

Role for Thromboxane Receptors in Angiotensin-II-Induced Hypertension

Helene Francois; Krairerk Athirakul; Lan Mao; Howard Rockman; and Thomas M. Coffman*

From Divisions of Nephrology (H.P., K.A., T.M.C.) and Cardiology (L.M., H.R.), Department of Medicine, Duke University, and Durham VA Medical Centers, Durham, NC.

* To whom correspondence should be addressed. E-mail: tcoffman{at}acpub.duke.edu.

Abstract--To evaluate the role of thromboxane in hypertension and its complications, we studied mice with targeted disruption of the TXA2 receptor gene in an angiotensin-II-dependent model of hypertension. To determine whether genetic background might alter the physiological actions of the TP receptor, we studied two lines of TP knockout (Tp-/-) mice with distinct genetic backgrounds (C57BL/6 and BALB/c). During chronic angiotensin II infusion (1000 ng/kg per minute x 28 days by subcutaneous osmotic pump), TP deficiency prevented mortality in the C57BL/6 background but not in the BALB/c strain. Chronic angiotensin II infusion also caused a rapid and significant increase in blood pressure in wild-type (WT) C57BL/6 and BALB/c animals, which was significantly attenuated in Tp-/- mice on either background. After 28 days of infusion, cardiac hypertrophy only occurred in the C57BL/6 strain: heart/body weight ratio increased by 57%±8% in WT mice compared with 17%±6.5% for the Tp-/- mice (P<0.01). Chronic angiotensin II infusion caused albuminuria only in the C57BL/6 strain, and TP deficiency did not alter its development. Cyclooxygenase-1 knockout mice also had attenuated blood pressure increase during chronic angiotensin II infusion, suggesting that cyclooxygenase-1 metabolites are involved in angiotensin-II-dependent hypertension. Thus, on the C57BL/6 background, TP receptors contribute to cardiac hypertrophy but not proteinuria. However, irrespective of genetic background, the TP receptor makes a robust contribution to the pathogenesis of angiotensin II-dependent hypertension.


Key words: thromboxane • hypertension • angiotensin II • hypertrophy • proteinuria • cyclooxygenase




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
H. Cheng, X. Fan, Y. Guan, G. W. Moeckel, R. Zent, and R. C. Harris
Distinct Roles for Basal and Induced COX-2 in Podocyte Injury
J. Am. Soc. Nephrol., September 1, 2009; 20(9): 1953 - 1962.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
C. S. Facemire, A. B. Nixon, R. Griffiths, H. Hurwitz, and T. M. Coffman
Vascular Endothelial Growth Factor Receptor 2 Controls Blood Pressure by Regulating Nitric Oxide Synthase Expression
Hypertension, September 1, 2009; 54(3): 652 - 658.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Yu, M. B. Lucitt, J. Stubbe, Y. Cheng, U. G. Friis, P. B. Hansen, B. L. Jensen, E. M. Smyth, and G. A. FitzGerald
Prostaglandin F2{alpha} elevates blood pressure and promotes atherosclerosis
PNAS, May 12, 2009; 106(19): 7985 - 7990.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Francois, N. Makhanova, P. Ruiz, J. Ellison, L. Mao, H. A. Rockman, and T. M. Coffman
A role for the thromboxane receptor in L-NAME hypertension
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1096 - F1102.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. D. Crowley, C. W. Frey, S. K. Gould, R. Griffiths, P. Ruiz, J. L. Burchette, D. N. Howell, N. Makhanova, M. Yan, H.-S. Kim, et al.
Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F515 - F524.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
S. B. Gurley and T. M. Coffman
Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages
Exp Physiol, May 1, 2008; 93(5): 538 - 542.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. M. Coffman and S. D. Crowley
Kidney in Hypertension: Guyton Redux
Hypertension, April 1, 2008; 51(4): 811 - 816.
[Full Text] [PDF]


Home page
Circ. Res.Home page
M. F. Navedo, M. Nieves-Cintron, G. C. Amberg, C. Yuan, V. S. Votaw, W. J. Lederer, G. S. McKnight, and L. F. Santana
AKAP150 Is Required for Stuttering Persistent Ca2+ Sparklets and Angiotensin II-Induced Hypertension
Circ. Res., February 1, 2008; 102(2): e1 - e11.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. Verlohren, M. Niehoff, L. Hering, N. Geusens, F. Herse, A. N. Tintu, A. Plagemann, F. LeNoble, R. Pijnenborg, D. N. Muller, et al.
Uterine Vascular Function in a Transgenic Preeclampsia Rat Model
Hypertension, February 1, 2008; 51(2): 547 - 553.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. B. Vagnes, B. M. Iversen, and W. J. Arendshorst
Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F860 - F867.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Francois, C. Facemire, A. Kumar, L. Audoly, B. Koller, and T. Coffman
Role of Microsomal Prostaglandin E Synthase 1 in the Kidney
J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1466 - 1475.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
A. Virdis, R. Colucci, M. Fornai, E. Duranti, C. Giannarelli, N. Bernardini, C. Segnani, C. Ippolito, L. Antonioli, C. Blandizzi, et al.
Cyclooxygenase-1 Is Involved in Endothelial Dysfunction of Mesenteric Small Arteries From Angiotensin II-Infused Mice
Hypertension, March 1, 2007; 49(3): 679 - 686.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. D. Crowley, S. B. Gurley, M. J. Herrera, P. Ruiz, R. Griffiths, A. P. Kumar, H.-S. Kim, O. Smithies, T. H. Le, and T. M. Coffman
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
PNAS, November 21, 2006; 103(47): 17985 - 17990.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Qi, H. Cai, J. D. Morrow, and M. D. Breyer
Differentiation of Cyclooxygenase 1- and 2-Derived Prostanoids in Mouse Kidney and Aorta
Hypertension, August 1, 2006; 48(2): 323 - 328.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. L. King, D. B. Trivedi, J. M. Gitlin, and C. D. Loftin
Selective Cyclooxygenase-2 Inhibition With Celecoxib Decreases Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Mice
Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1137 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. J. Mullins, M. A. Bailey, and J. J. Mullins
Hypertension, Kidney, and Transgenics: A Fresh Perspective
Physiol Rev, April 1, 2006; 86(2): 709 - 746.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Zhang, C. DiLizio, D. Kim, E. M. Smyth, and D. R. Manning
The G12 Family of G Proteins as a Reporter of Thromboxane A2 Receptor Activity
Mol. Pharmacol., April 1, 2006; 69(4): 1433 - 1440.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
L. Wang, T. A. Fields, K. Pazmino, Q. Dai, J. L. Burchette, D. N. Howell, T. M. Coffman, and R. F. Spurney
Activation of G{alpha}q-Coupled Signaling Pathways in Glomerular Podocytes Promotes Renal Injury
J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3611 - 3622.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Wilcox
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. Kawada, K. Dennehy, G. Solis, P. Modlinger, R. Hamel, J. T. Kawada, S. Aslam, T. Moriyama, E. Imai, W. J. Welch, et al.
TP receptors regulate renal hemodynamics during angiotensin II slow pressor response
Am J Physiol Renal Physiol, October 1, 2004; 287(4): F753 - F759.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
J.-J. Boffa, A. Just, T. M. Coffman, and W. J. Arendshorst
Thromboxane Receptor Mediates Renal Vasoconstriction and Contributes to Acute Renal Failure in Endotoxemic Mice
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2358 - 2365.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Wang, T. Chabrashvili, and C. S. Wilcox
Enhanced Contractility of Renal Afferent Arterioles From Angiotensin-Infused Rabbits: Roles of Oxidative Stress, Thromboxane Prostanoid Receptors, and Endothelium
Circ. Res., June 11, 2004; 94(11): 1436 - 1442.
[Abstract] [Full Text] [PDF]